Universal reference book for medicines
Product name: OTIPAX ® (OTIPAX ® )

Active substance: lidocaine, phenazone

Type: The drug with anti-inflammatory and local anesthetic action for topical application in ENT practice

Manufacturer: BIOCODEX (France)
Composition, form of production and packaging
?
Ear drops are a clear, colorless or yellowish solution with the smell of alcohol.
1 g

phenazone 40 mg

lidocaine hydrochloride 10 mg

Excipients: sodium thiosulfate - 1 mg, ethanol - 221.8 mg, glycerol - 709 mg, water - 18.2 mg.

16 g - bottles of dark glass (1) complete with a dropper (in a blister) - cardboard boxes.

INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2016.

PHARMACHOLOGIC EFFECT

Phenazone has an anti-inflammatory and analgesic effect.

Lidocaine has a local anesthetic effect.

PHARMACOKINETICS

Does not penetrate the body with intact tympanic membrane.

INDICATIONS

For local symptomatic treatment and analgesia in adults and children (including newborns) with:

- average otitis in the acute period at the time of inflammation;

- Otitis, as a complication after the flu;

- barotraumatic otitis media.

DOSING MODE

Drops are instilled into the external auditory meatus by 3-4 drops 2-3 times / day.
To avoid contact of the cold solution with the auricle, the bottle should be warmed in the palms before use.
The duration of application of Otipaks ® is no more than 10 days, then the prescribed treatment should be reviewed.

SIDE EFFECT

Probably: allergic reactions, irritation and hyperemia of the auditory canal.

CONTRAINDICATIONS

perforation of the tympanic membrane;

- Hypersensitivity to the components of the drug.

PREGNANCY AND LACTATION

It is possible to use Otipaks ® during pregnancy and lactation as indicated by the condition of the intact tympanic membrane.

SPECIAL INSTRUCTIONS

Before using the drug, you need to ensure the integrity of the tympanic membrane.

In case of using the drug with a perforated tympanic membrane, the drug can come into contact with the organs of the middle ear and lead to complications.

Information for athletes

The drug contains an active ingredient, which can give a positive reaction in doping control.

OVERDOSE

Data on the overdose of Otipaks ® are not available.

DRUG INTERACTION

Currently, there is no data on the interaction of Otipax ® with other drugs.

TERMS OF RELEASE FROM PHARMACY

The drug is dispensed without a prescription.

TERMS AND CONDITIONS OF STORAGE

The drug should be stored out of reach of children at a temperature of no higher than 30 ° C.
Shelf life - 5 years. Do not use after the expiration date printed on the package.
After opening the vial, the drug should be used within 6 months.

Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!